All amphetamines · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dexamphetamine · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Retention in treatment · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
Amphetamines showed no clear difference in retention in treatment compared with placebo (low certainty).
1 finding from 1 review
ADHD symptom severity: clinician rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
3 findings from 1 review
no estimate extracted
1 study · 49 participants
Very low
no estimate extracted
7 studies · 896 participants
Low
no estimate extracted
5 studies · 1083 participants
Low
ADHD symptom severity: patient rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
3 findings from 1 review
no estimate extracted
2 studies · 35 participants
Low
no estimate extracted
3 studies · 67 participants
Low
no estimate extracted
1 study · 18 participants
Very low
Lisdexamfetamine · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mixed amphetamine salts · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Total ADHD symptom score ‐ parent ratings (ADHD Rating Scale, Fourth Version; Conners' Rating Scale; Conners' Global Index; Conners' Abbreviated Symptom Questionnaire) · children or adolescents with ADHD
It is very uncertain whether the intervention changes total ADHD symptom score ‐ parent ratings (ADHD Rating Scale, Fourth… (very low certainty).
1 finding from 1 review
Intervention not reported
Total ADHD symptom score ‐ teacher ratings (ADHD Rating Scale, Fourth Version; Conners' Rating Scale; Conners' Global Index; Conners' Abbreviated Symptom Questionnaire) · children or adolescents with ADHD
The intervention showed no clear difference in total ADHD symptom score ‐ teacher ratings (ADHD Rating Scale,… (low certainty).
1 finding from 1 review
Intervention not reported
Total ADHD symptom score ‐ clinician ratings (ADHD Rating Scale, Fourth Version) · children or adolescents with ADHD
It is very uncertain whether the intervention changes total ADHD symptom score ‐ clinician ratings (ADHD Rating Scale,… (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of responders (Clinical Global Impressions ‐ Improvement (CGI‐I) scale) · children or adolescents with ADHD
It is very uncertain whether the intervention changes proportion of responders (Clinical Global Impressions ‐ Improvement… (very low certainty).
1 finding from 1 review
Intervention not reported
Academic performance (Permanent Product Measure of Performance; Wechsler Intelligence Scale for Children ‐ Revised; Barnell Lot, Ltd Math Test; Wide Range Achievement Test) · children or adolescents with ADHD
The intervention may leads to higher academic performance (Permanent Product Measure of Performance;… (low certainty).
1 finding from 1 review
Intervention not reported
Retention: proportion of participants who completed the trial · children or adolescents with ADHD
It is very uncertain whether the intervention changes retention: proportion of participants who completed the trial (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of participants who experienced at least 1 adverse event · children or adolescents with ADHD
The intervention may leads to higher proportion of participants who experienced at least 1 adverse event (low certainty).
1 finding from 1 review